2025 Acute Coronary Syndromes Guideline

https://is1-ssl.mzstatic.com/image/thumb/Podcasts211/v4/88/e3/7d/88e37d56-b90a-9216-df54-eb41ce6dc75f/mza_11170658607152880398.jpg/600x600bb.jpg

Hu Said: Cardiology Board Review Series

Ruey Hu, MD, MPH

108 episodes

2 weeks ago

Welcome to Hu Said, a cardiology #MedEd podcast. Every episode cuts straight to the core of the topic, delivering the high-yield information you need to know for your exams. In this 2nd season of the podcast, new topics have been added, with >100 total topics. Whenever possible, evidence-based statements from the latest ACC/AHA/HRS/HFSA/SCAI guidelines are interwoven. Whether you are a resident, fellow, or re-certifying cardiologist, subscribe for precise, curated pearls. Ensure you get maximum knowledge in minimal time, because your time is valuable. X: @ruey_hu Materials: rueyhu.com/MedEd

Courses

Education

RSS

All content for Hu Said: Cardiology Board Review Series is the property of Ruey Hu, MD, MPH and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.

Courses

Education

https://d3t3ozftmdmh3i.cloudfront.net/staging/podcast_uploaded_nologo/41082154/41082154-1716780829746-1560fe6c85388.jpg

2025 Acute Coronary Syndromes Guideline

Hu Said: Cardiology Board Review Series

48 minutes 7 seconds

9 months ago

2025 Acute Coronary Syndromes Guideline

Should non-culprit lesions be revascularized in STEMI and NSTEMI? Should revascularization of non-culprit lesions occur in a simultaneous or staged manner? How do these recommendations differ when acute MI presents with cardiogenic shock? When DAPT is reduced to SAPT, which P2Y12 inhibitor is favored for monotherapy? When is de-escalation from ticagrelor/prasugrel to clopidogrel reasonable? In post-PCI patients requiring antithrombotic therapy, what should the duration of triple therapy be, and what is the P2Y12 inhibitor of choice? What is the role of Impella, IABP, and VA-ECMO in ACS with cardiogenic shock? Tune in for answers to these questions in this "deep dive" of the 2025 AHA/ACC Guideline for the Management of Patients with Acute Coronary Syndromes.

Difficulty Level: Intermediate

You are listening to Hu Said: Guideline Lifeline

Please subscribe, rate, and support the channel! Ads help keep materials free for everyone.

More MedEd resources available at ⁠⁠www.rueyhu.com⁠⁠

Updates at Twitter/X: ⁠⁠@Ruey_Hu⁠